Insider · CIK 0001677036

Lind Kevin Robert

Reports to the SEC for 4 companies · WAYNE, PA

sec.gov

Transactions

Companies

Filings

CIK

0001677036

Forms 4 and 5

Insider transactions

46 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-09-30	AVTXAvalo Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+1,352 sh	$12.29	+$16.6K	1,352
2026-08-03	APMDApnimed, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−109K sh	—	—	0
2026-08-03	APMDApnimed, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−1.19M sh	—	—	0
2026-08-03	APMDApnimed, Inc. · Stock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+1.19M sh	—	—	1,186,278
2026-08-03	APMDApnimed, Inc. · Stock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+109K sh	—	—	108,916
2026-08-03	APMDApnimed, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−74.1K sh	—	—	0
2026-08-03	APMDApnimed, Inc. · Stock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+74.1K sh	—	—	74,128
2026-07-30	APMDApnimed, Inc. · Stock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+109K sh	—	—	108,916
2026-06-30	AVTXAvalo Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+1,105 sh	$15.04	+$16.6K	1,105
2026-06-02	AVTXAvalo Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+20.1K sh	—	—	20,100
2026-03-31	AVTXAvalo Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+1,370 sh	$12.13	+$16.6K	1,370
2025-12-31	AVTXAvalo Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+848 sh	$14.74	+$12.5K	848
2025-10-01	AVTXAvalo Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+40.2K sh	—	—	40,200
2024-12-02	Longboard Pharmaceuticals, Inc.U Disposition from Tender	Director, President and CEO	UDisposition from Tender	−364K sh	$60.00	−$21.8M	0
2024-12-02	Longboard Pharmaceuticals, Inc.Restricted Stock UnitD Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−22K sh	—	—	0
2024-12-02	Longboard Pharmaceuticals, Inc.Employee Stock Option (right to buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−193K sh	—	—	0
2024-12-02	Longboard Pharmaceuticals, Inc.Employee Stock Option (right to buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−326K sh	—	—	0
2024-12-02	Longboard Pharmaceuticals, Inc.Employee Stock Option (right to buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−332K sh	—	—	0
2024-12-02	Longboard Pharmaceuticals, Inc.Employee Stock Option (right to buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−255K sh	—	—	0
2024-11-13	Longboard Pharmaceuticals, Inc.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+12.8K sh	$3.12	+$40K	443,740
2024-11-13	Longboard Pharmaceuticals, Inc.G Gift	Director, President and CEO	GGift	−80K sh	—	—	363,740
2024-11-13	Longboard Pharmaceuticals, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−12.8K sh	—	—	255,377
2024-10-25	Longboard Pharmaceuticals, Inc.Retention Restricted Stock UnitsA Award	Director, President and CEO	AAward	+22K sh	—	—	22,000
2024-08-12	Longboard Pharmaceuticals, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−2,217 sh	—	—	192,783
2024-08-12	Longboard Pharmaceuticals, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−80.3K sh	—	—	268,185
2024-08-12	Longboard Pharmaceuticals, Inc.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+80.3K sh	$3.12	+$251K	428,715
2024-08-12	Longboard Pharmaceuticals, Inc.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+2,217 sh	$4.20	+$9,311.4	430,932
2024-02-08	Longboard Pharmaceuticals, Inc.Stock Option (Right to Buy)A Award	Director, President and CEO	AAward	+332K sh	—	—	332,134
2023-02-09	Longboard Pharmaceuticals, Inc.Stock Option (Right to Buy)A Award	Director, President and CEO	AAward	+326K sh	—	—	325,850
2022-02-09	Longboard Pharmaceuticals, Inc.Stock Option (Right to Buy)A Award	Director, President and CEO	AAward	+195K sh	—	—	195,000
2020-03-01	ARENA PHARMACEUTICALS INCEmployee Stock Option (right to buy)A Award	Executive VP and CFO	AAward	+70K sh	—	—	70,000
2020-02-13	ARENA PHARMACEUTICALS INCEmployee Stock Option (right to buy)M Exercise/Conversion	Executive VP and CFO	MExercise/Conversion	−2,000 sh	—	—	128,000
2020-02-13	ARENA PHARMACEUTICALS INCEmployee Stock Option (right to buy)M Exercise/Conversion	Executive VP and CFO	MExercise/Conversion	−2,500 sh	—	—	77,500
2020-02-13	ARENA PHARMACEUTICALS INCS Sale	Executive VP and CFO	SSale	−4,500 sh	$55.00	−$248K	3,457
2020-02-13	ARENA PHARMACEUTICALS INCM Exercise/Conversion	Executive VP and CFO	MExercise/Conversion	+2,000 sh	$35.60	+$71.2K	7,957
2020-02-13	ARENA PHARMACEUTICALS INCM Exercise/Conversion	Executive VP and CFO	MExercise/Conversion	+2,500 sh	$19.40	+$48.5K	5,957
2019-10-14	ARENA PHARMACEUTICALS INCPerformance Restricted Stock UnitM Exercise/Conversion	Executive VP and CFO	MExercise/Conversion	−6,300 sh	—	—	18,900
2019-10-14	ARENA PHARMACEUTICALS INCM Exercise/Conversion	Executive VP and CFO	MExercise/Conversion	+6,300 sh	—	—	6,548
2019-10-14	ARENA PHARMACEUTICALS INCF Tax Payment	Executive VP and CFO	FTax Payment	−3,091 sh	$47.32	−$146K	3,457
2019-01-04	ARENA PHARMACEUTICALS INCEmployee Performance Restricted Stock UnitA Award	Executive VP and CFO	AAward	+12.6K sh	—	—	12,600
2019-01-04	ARENA PHARMACEUTICALS INCEmployee Stock Option (right to buy)A Award	Executive VP and CFO	AAward	+75K sh	—	—	75,000
2018-01-19	ARENA PHARMACEUTICALS INCEmployee Stock Option (right to buy)A Award	Executive VP and CFO	AAward	+130K sh	—	—	130,000
2017-02-13	ARENA PHARMACEUTICALS INCEmployee Stock Option (right to buy)A Award	Executive VP and CFO	AAward	+1.04M sh	—	—	1,044,750
2016-12-30	ARENA PHARMACEUTICALS INCJ Other	Executive VP and CFO	JOther	+625 sh	$1.21	+$756.25	1,250
2016-09-30	ARENA PHARMACEUTICALS INCJ Other	Executive VP and CFO	JOther	+625 sh	$1.41	+$881.25	625
2016-06-15	ARENA PHARMACEUTICALS INCEmployee Stock Option (right to buy)A Award	Executive VP and CFO	AAward	+800K sh	—	—	800,000

Recent filings

Accepted (ET)
Oct 24
Lind Kevin Robert0001677036-26-000009
SEC(opens sec.gov)
Aug 34
Lind Kevin Robert0001193125-26-330505
SEC(opens sec.gov)
Jul 24
Lind Kevin Robert0001677036-26-000006
SEC(opens sec.gov)
Jun 44
Lind Kevin Robert0001677036-26-000004
SEC(opens sec.gov)
Apr 14
Lind Kevin Robert0001677036-26-000002
SEC(opens sec.gov)
Jan 54
Lind Kevin Robert0001470831-26-000007
SEC(opens sec.gov)
Oct 24
Lind Kevin Robert0001677036-25-000004
SEC(opens sec.gov)
Dec 24
Lind Kevin Robert0001415889-24-028021
SEC(opens sec.gov)
Nov 134
Lind Kevin Robert0000950170-24-126650
SEC(opens sec.gov)

Companies

Address

C/O AVALO THERAPEUTICS, INC. 1500 LIBERTY RIDGE DRIVE, SUITE 321

WAYNE, PA, 19087